WO2011082196A3 - Rapid reconstitution for lyophilized-pharmaceutical suspensions - Google Patents

Rapid reconstitution for lyophilized-pharmaceutical suspensions Download PDF

Info

Publication number
WO2011082196A3
WO2011082196A3 PCT/US2010/062289 US2010062289W WO2011082196A3 WO 2011082196 A3 WO2011082196 A3 WO 2011082196A3 US 2010062289 W US2010062289 W US 2010062289W WO 2011082196 A3 WO2011082196 A3 WO 2011082196A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
pharmaceutical active
sterile
lyophilized pharmaceutical
lyophilized
less
Prior art date
Application number
PCT/US2010/062289
Other languages
French (fr)
Other versions
WO2011082196A2 (en )
Inventor
Wei Y. Kuu
Original Assignee
Baxter International Inc.
Baxter Healthcare S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins

Abstract

A method of preparing and reconstituting a sterile, lyophilized pharmaceutical active for rapid reconstitution by evacuating a lyophilized pharmaceutical active-containing container until the pressure within the container is less than about 300 Torr and hermetically sealing the evacuated container. The sterile, lyophilized pharmaceutical active can be prepared by flash freezing a pharmaceutical active-containing composition then lyophilizing the composition. The hermetically sealed lyophilized pharmaceutical active can be reconstituted by adding at least the total volume of liquid necessary for reconstitution of the sterile, lyophilized pharmaceutical active to the sterile, lyophilized pharmaceutical active, sealed under a pressure of less than about 300 Torr, in less than about 10 seconds to yield, within about 5 minutes, an administrable pharmaceutical active-containing composition. One aspect of the herein described sterile, lyophilized pharmaceutical active is a packaged sterile pharmaceutical active comprising an evacuated, hermetically sealed container having disposed therein a sterile, lyophilized pharmaceutical active, sealed under a pressure of less than about 300 Torr.
PCT/US2010/062289 2009-12-30 2010-12-29 Rapid reconstitution for lyophilized-pharmaceutical suspensions WO2011082196A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US29099809 true 2009-12-30 2009-12-30
US61/290,998 2009-12-30

Publications (2)

Publication Number Publication Date
WO2011082196A2 true WO2011082196A2 (en) 2011-07-07
WO2011082196A3 true true WO2011082196A3 (en) 2011-09-15

Family

ID=44146708

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/062289 WO2011082196A3 (en) 2009-12-30 2010-12-29 Rapid reconstitution for lyophilized-pharmaceutical suspensions

Country Status (2)

Country Link
US (1) US20110155620A1 (en)
WO (1) WO2011082196A3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8371039B2 (en) 2009-12-30 2013-02-12 Baxter International Inc. Thermal shielding to optimize lyophilization process for pre-filled syringes or vials
EP2773778A4 (en) * 2011-10-31 2015-07-15 Merck Sharp & Dohme Methods of preparing lyophilized spherical-shaped pellets of biological materials
JP5814094B2 (en) * 2011-11-30 2015-11-17 ふたみ青果株式会社 Freeze drying method and apparatus according to the far-infrared heater
US9731076B2 (en) 2012-06-29 2017-08-15 Ethicon, Inc. Multi-compartment pre-filled mixing syringes with bypass
KR20160135176A (en) * 2014-01-20 2016-11-25 유씨비 바이오파마 에스피알엘 Process for reconstitution of a solid form of a pharmaceutical composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053174A2 (en) * 2000-12-29 2002-07-11 Pbl Biomedical Laboratories Controlled release pharmaceutical systems
US20060134221A1 (en) * 2004-12-03 2006-06-22 Vical Incorporated Methods for producing block copolymer/amphiphilic particles
WO2006081320A2 (en) * 2005-01-27 2006-08-03 Human Genome Sciences, Inc. Pharmaceutical formulation
WO2007027819A2 (en) * 2005-08-31 2007-03-08 Abraxis Bioscience, Llc. Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768341B1 (en) 1997-09-18 2000-04-14 Lab Francais Du Fractionnement placebo pharmaceutical composition lyophilizable FOR imitate a medicament, in particular a basic protein or polypeptide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053174A2 (en) * 2000-12-29 2002-07-11 Pbl Biomedical Laboratories Controlled release pharmaceutical systems
US20060134221A1 (en) * 2004-12-03 2006-06-22 Vical Incorporated Methods for producing block copolymer/amphiphilic particles
WO2006081320A2 (en) * 2005-01-27 2006-08-03 Human Genome Sciences, Inc. Pharmaceutical formulation
WO2007027819A2 (en) * 2005-08-31 2007-03-08 Abraxis Bioscience, Llc. Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MAKHAEVA G F ET AL: "A stable preparation of hen brain neuropathy target esterase for rapid biochemical assessment of neurotoxic potential of organophosphates", CHEMICO-BIOLOGICAL INTERACTIONS, ELSEVIER SCIENCE IRLAND, IR, vol. 119-120, 14 May 1999 (1999-05-14), pages 551-557, XP027424526, ISSN: 0009-2797, DOI: DOI:10.1016/S0009-2797(99)00069-1 [retrieved on 1999-05-14] *
TATTINI VIRGILIO JR ET AL: "Influence of cooling rate on the structural and phase changes during lyophilization of bovine serum albumin", REVISTA BRASILEIRA DE CIENCIAS FARMACEUTICAS, vol. 42, no. 1, January 2006 (2006-01), pages 127-136, XP009149556, ISSN: 1516-9332 *

Also Published As

Publication number Publication date Type
WO2011082196A2 (en) 2011-07-07 application
US20110155620A1 (en) 2011-06-30 application

Similar Documents

Publication Publication Date Title
US6739112B1 (en) Bone allograft packaging system
WO2005117962A1 (en) Preservation by vaporization
US20090223080A1 (en) Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
WO2009126309A3 (en) Atherectomy devices and methods
CN202244671U (en) Conveniently vacuumized sealing container
CN1911255A (en) Anti-oxidation tech. for wall-breaked glossy ganoderma spore powder
CN101768554A (en) Technological method for breaking cell walls of ganoderma lucidum spore powder
CN101780045A (en) Cefoxitin sodium powder-needle preparation for injection and preparation method thereof
CN102863685A (en) Fresh-keeping packaging material for tomatoes
US20110178470A1 (en) Pharmaceutical compositions comprising boronic acid compounds
CN102726553A (en) Method for processing cold-making green tea
CN203958732U (en) Powder and liquid double-room bag production system
CN202236306U (en) Multilayer co-extrusion transfusion double-chamber bag
CN101084943A (en) Method for preparing mixture containing natural vitamin P from sea-buckthorn
WO2012098358A1 (en) Freeze drying method
CN102396702A (en) Production method of active substance compound powder of hericium erinaceus and lucid ganoderma and product thereof
CN102688204A (en) S-pantoprazole sodium freeze-drying medicament composition and preparation method thereof
CN101965860A (en) Method for processing quick-frozen fresh lotus
CN101947208A (en) Fludarabine phosphate composition for injection and preparation method thereof
CN202052023U (en) Positive pressure leak detection high-capacity soft bag infusion
CN103694365A (en) Ultrahigh-pressure extraction process of tricholoma matsutake polysaccharide
US8586119B2 (en) Distributing products which comprise coconut water
CN103704206A (en) Placenta preserving fluid
CN101829065A (en) Lansoprazole composition freeze-dried powder for injection
CN104528205A (en) Lithium battery pack packaging box

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10801080

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 10801080

Country of ref document: EP

Kind code of ref document: A2